Cas:33468-69-8 4-(Trifluoromethyl)-1H-imidazole manufacturer & supplier

We serve Chemical Name:4-(Trifluoromethyl)-1H-imidazole CAS:33468-69-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(Trifluoromethyl)-1H-imidazole

Chemical Name:4-(Trifluoromethyl)-1H-imidazole
CAS.NO:33468-69-8
Synonyms:4-trifluoromethylimidazole;4-trifluoromethyl-1H-imidazole;1H-Imidazole, 4-(trifluoromethyl)-;4-(Trifluoromethyl)-1H-imidazole;Imidazole,4-trifluoromethyl;4(5)-(Trifluoromethyl)imidazole
Molecular Formula:C4H3F3N2
Molecular Weight:136.075
HS Code:2933290090

Physical and Chemical Properties:
Melting point:149-150ºC
Boiling point:224.7±35.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.417
PSA:28.68000
Exact Mass:136.024826
LogP:0.41

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-trifluoromethylimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4(5)-(Trifluoromethyl)imidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(Trifluoromethyl)-1H-imidazole Use and application,4(5)-(Trifluoromethyl)imidazole technical grade,usp/ep/jp grade.


Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. 4-(Trifluoromethyl)-1H-imidazole manufacturer But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. 4-(Trifluoromethyl)-1H-imidazole supplier An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 4-(Trifluoromethyl)-1H-imidazole vendor An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 4-(Trifluoromethyl)-1H-imidazole factory An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.